Evidence map›Paper›PMID 29073197›Full record

ArticlePloS one2017

Etiology and mode of presentation of chronic liver diseases in India: A multi centric study.

Partha S Mukherjee, Sreenivas Vishnubhatla, Deepak N Amarapurkar, Kausik Das, Ajit Sood, Yogesh K Chawla, Chundamannil E Eapen, Prabhakar Boddu, Varghese Thomas, Subodh Varshney and 5 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 131 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Effect of long-term aggressive nutrition therapy on survival in patients with alcohol-related cirrhosis: A randomized controlled trial.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2022
    Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. The Use ofBiomedicines · 2024
    Review
  16. Article
  17. Article
  18. Article
  19. Global epidemiology of cirrhosis - aetiology, trends and predictions.Nature reviews. Gastroenterology & hepatology · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 11 institutions in 1 country.

Partha S MukherjeeLiver Foundation, West Bengal. Kolkata, West Bengal, India.
Sreenivas VishnubhatlaDepartment of Biostatistics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.
Deepak N AmarapurkarBombay Hospital & Medical Research Centre, Mumbai, India.
Kausik DasDepartment of Hepatology, School of Digestive and liver Diseases, Institute of Post Graduate Medical Education & Research, Kolkata, India.
Ajit SoodDepartment of Gastroenterology, Dayanand Medical College & Hospital, Ludhiana, Punjab, India.
Yogesh K ChawlaDepartment of Hepatology, Post Graduate Institute of Medical Sciences, Chandigarh, India.
Chundamannil E EapenDepartment of Hepatology, Christian Medical College, Vellore, India.
Prabhakar BodduDepartment of Gastroenterology, Osmania General Hospital, Afzalgunj, Hyderabad, Telangana, India.
Varghese ThomasDepartment of Gastroenterology, Calicut Medical College, Kozhikode, Kerala, India.
Subodh VarshneyDepartment of Surgical Gastroenterology, Bhopal Memorial Hospital and Research Centre, Bhopal, Madhya Pradesh, India.
Diamond Sharma HidangmayumCatholic medical centre hospital, Koirengei, Imphal East, Manipur, India.
Pradip BhaumikDepartment of medicine, Agartala Govt Medical College, Agartala, Tripura, India.
Bhaskar ThakurDepartment of Biostatistics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.
Subrat K AcharyaDepartment of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.
Abhijit ChowdhuryDepartment of Hepatology, School of Digestive and liver Diseases, Institute of Post Graduate Medical Education & Research, Kolkata, India.ORCID http://orcid.org/0000-0003-4207-0923
All India Institute of Medical Sciences · INInstitute of Post Graduate Medical Education and Research · INAgartala Government Medical College · INBhopal Memorial Hospital & Research Centre · INBombay Hospital · INChristian Medical College, Vellore · INDayanand Medical College & Hospital · INGovernment Medical College · INLiver Foundation West Bengal · INOsmania General Hospital · INPost Graduate Institute of Medical Education and Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is a paucity of health policy relevant data for chronic liver disease from India, impeding formulation of an interventional strategy to address the issue. A prospective, multicentric study to delineate the etiology and clinical profile of chronic liver disease in India is reported here. A centrally coordinated and monitored web-based data repository was developed (Feb, 2010 to Jan, 2013) and analyzed. Eleven hospitals from different parts of India participated. Data were uploaded into a web based proforma and monitored by a single centre according to a standardized protocol. 1.28% (n = 266621) of all patients (n = 20701383) attending the eleven participating hospitals of India had liver disease. 65807 (24·68%) were diagnosed for the first time (new cases). Of these, 13014 (19·77%, median age 43 years, 73% males) cases of chronic liver disease were finally analyzed. 33.9% presented with decompensated cirrhosis. Alcoholism (34·3% of 4413) was the commonest cause of cirrhosis while Hepatitis B (33·3%) was predominant cause of chronic liver disease in general and non-cirrhotic chronic liver disease (40·8% out of 8163). There was significant interregional differences (hepatitis C in North, hepatitis B in East and South, alcohol in North-east, Non-alcoholic Fatty Liver Disease in West) in the predominant cause of chronic liver disease. Hepatitis B (46·8% of 438 cases) was the commonest cause of hepatocellular Cancer.11·7% had diabetes. Observations of our study will help guide a contextually relevant liver care policy for India and could serve as a framework for similar endeavor in other developing countries as well.

Indexed as

AdolescentAdultAgedAged, 80 and overChildChild, PreschoolChronic DiseaseFemaleHealth FacilitiesHealth Services AccessibilityHumansIndiaInfantLiver DiseasesMaleMiddle Aged

Identifiers

PMID29073197
PMCPMC5658106
OpenAlexW2765709478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.